Literature DB >> 18583084

Stability indicating UPLC method for simultaneous determination of atorvastatin, fenofibrate and their degradation products in tablets.

A A Kadav1, D N Vora.   

Abstract

A stability indicating UPLC method was developed and validated for the simultaneous determination of atorvastatin, fenofibrate and their impurities in tablets. The chromatographic separation was performed on acquity UPLC BEH C18 column (1.7 microm, 2.1 mmx100 mm) using gradient elution of acetonitrile and ammonium acetate buffer (pH 4.7; 0.01 M) at flow rate of 0.5 ml/min. UV detection was performed at 247 nm. Total run time was 3 min within which main compounds and six other known and major unknown impurities were separated. Stability indicating capability was established by forced degradation experiments and separation of known degradation products. The method was validated for accuracy, repeatability, reproducibility and robustness. Linearity, LOD and LOQ was established for atorvastatin, fenofibrate and their known impurities.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18583084     DOI: 10.1016/j.jpba.2008.05.018

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  10 in total

1.  Development and validation of a UPLC method for rapid and simultaneous analysis of proton pump inhibitors.

Authors:  Richard T Addo; Kenneth Davis; Ruhi Ubale; Joel S Owen; E Blake Watkins
Journal:  AAPS PharmSciTech       Date:  2014-08-27       Impact factor: 3.246

2.  UHPLC: The Greening Face of Liquid Chromatography.

Authors:  Judyta Cielecka-Piontek; Przemysław Zalewski; Anna Jelińska; Piotr Garbacki
Journal:  Chromatographia       Date:  2013-03-07       Impact factor: 2.044

3.  Simultaneous quantitative determination of metoprolol, atorvastatin and ramipril in capsules by a validated stability-indicating RP-UPLC method.

Authors:  Raja Kumar Seshadri; Makarand Madhukar Desai; Thummala Veera Raghavaraju; Deepa Krishnan; Dama Venugopala Rao; Ivon Elisha Chakravarthy
Journal:  Sci Pharm       Date:  2010-08-24

4.  Synchronized separation of atorvastatin-an antihyperlipidemic drug with antihypertensive, antidiabetic, antithrombotic drugs by RP-LC for determination in combined formulations.

Authors:  M V N Kumar Talluri; Anitha Kalyankar; Srinivas Ragampeta
Journal:  J Pharm Anal       Date:  2012-03-13

5.  Superiority of Mesoporous Silica-Based Amorphous Formulations over Spray-Dried Solid Dispersions.

Authors:  Hongwei Zhang; Minglu Li; Jianmin Li; Anjali Agrawal; Ho-Wah Hui; Demin Liu
Journal:  Pharmaceutics       Date:  2022-02-16       Impact factor: 6.321

6.  A Validated LC-MS/MS Assay for the Simultaneous Quantification of the FDA-Approved Anticancer Mixture (Encorafenib and Binimetinib): Metabolic Stability Estimation.

Authors:  Mohamed W Attwa; Hany W Darwish; Nasser S Al-Shakliah; Adnan A Kadi
Journal:  Molecules       Date:  2021-05-05       Impact factor: 4.411

7.  Comprehensive Assessment of Degradation Behavior of Aspirin and Atorvastatin Singly and in Combination by Using a Validated RP-HPLC Method.

Authors:  Omkar Sherikar; Priti Mehta
Journal:  Sci Pharm       Date:  2012-12-11

8.  Performance evaluation of a novel potentiometric membrane sensor for determination of atorvastatin in pharmaceutical preparations.

Authors:  Farhad Ahmadi; Nasim Asaadi
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

9.  Preparation and Characterization of Fenofibrate Microparticles with Surface-Active Additives: Application of a Supercritical Fluid-Assisted Spray-Drying Process.

Authors:  Jeong-Soo Kim; Heejun Park; Eun-Sol Ha; Kyu-Tae Kang; Min-Soo Kim; Sung-Joo Hwang
Journal:  Pharmaceutics       Date:  2021-12-02       Impact factor: 6.321

10.  Simultaneous separation of antihyperlipidemic drugs by green ultrahigh-performance liquid chromatography-diode array detector method: Improving the health of liquid chromatography.

Authors:  Mansoor Alghazi; Fars Alanazi; Kazi Mohsin; Nasir Ali Siddiqui; Faiyaz Shakeel; Nazrul Haq
Journal:  J Food Drug Anal       Date:  2016-06-05       Impact factor: 6.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.